Interview w/ Eyal Barad, Cannabics Pharmaceuticals Inc. CEO on Cannabis Treating Colorectal Cancer
M4A•Αρχική οθόνη επεισοδίου
Manage episode 317382511 series 3101160
Το περιεχόμενο παρέχεται από το Marc Eden. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Marc Eden ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
Marc Eden interviews Eyal Barad, Co-founder and CEO of Cannabics Pharmaceuticals, Inc (CNBX) about their cannabis biotech company and groundbreaking cannabinoid based anti-tumor drug for treating colorectal cancer. Cannabics Pharmaceuticals is based in Maryland in the United States, however their cannabis medicine R&D is located in Israel. Cannabics Pharmaceuticals Inc. has the world’s first cannabinoid based anti-tumor drug candidate for treating colorectal cancer based on their novel and proprietary IP. Other topics discussed include Cannabics milestones, cannabinoids, terpenes, cannabis legalization across the world, and home growing. Listen to hear Eyal Barad’s take on cannabis and cancer, cannabis as medicine, and even on who is leading Europe in cannabis policy. Eyal also weighs in on the opportunity for home growing and cannabis medicine. --- Send in a voice message: https://podcasters.spotify.com/pod/show/green-carpet-growing/message Support this podcast: https://podcasters.spotify.com/pod/show/green-carpet-growing/support
…
continue reading
24 επεισόδια